Patient-Reported Symptom Score Predicts Outcome in Amyloidosis

Share this content:
Patient-Reported Symptom Score Predicts Outcome in Amyloidosis
Patient-Reported Symptom Score Predicts Outcome in Amyloidosis

MONDAY, Feb. 13, 2017 (HealthDay News) -- A patient-reported symptom score can help predict clinical outcomes in patients with light-chain amyloidosis (AL), according to a study published online Feb. 9 in the American Journal of Hematology.

Rahma Warsame, M.D., from the Mayo Clinic in Rochester, Minn., and colleagues prospectively employed a Hematology Patient Reported Symptom Screen (HPRSS), which included three questions relating to pain, fatigue, and quality of life (QOL), for 302 newly diagnosed patients with AL from 2009 to 2014.

The researchers found that the median overall survival was 53 months, and 102 deaths occurred in the first year. Baseline HPRSS differed significantly for those who lived longer than one year and early-death patients in the domains of fatigue (5 versus 7; P < 0.0001) and QOL (6 versus 5; P = 0.006). Fatigue, QOL, physician-reported performance status, autologous stem cell transplant (ASCT), and Mayo stage were prognostic for survival on univariate analysis. Mayo stage, ASCT, and baseline fatigue remained independently prognostic on multivariate analysis. QOL scores improved significantly over time among the 125 patients with HPRSS measurements at 12 months (6 to 7; P = 0.01).

"Baseline patient-reported fatigue is an independent prognostic factor for survival," the authors write. "Survival at one year was associated with significant improvement in QOL."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Recent Decline in Prescription Opioid Use Among U.S. Teens

Recent Decline in Prescription Opioid Use Among U.S. ...

Lifetime prevalence of use peaked in 1989, 2002, and remained stable until decline in 2013 to 2015

Treatment Seeking Low Among Teens With Eating Disorders

Treatment Seeking Low Among Teens With Eating Disorders

Those with counter-stereotypic presentation even less likely to seek treatment

Optical Clearing Agent Ups No. of Laser Passes in Tattoo Removal

Optical Clearing Agent Ups No. of Laser Passes ...

Findings based on number of laser passes during a five-minute tattoo removal session

is free, fast, and customized just for you!

Already a member?

Sign In Now »